New Haven, CT (April 30, 2021) - Yale New Haven Health (YNHHS) is proud to announce that its Outpatient Pharmacy Services has earned full URAC 4.0 re-accreditation in Specialty Pharmacy. URAC is the Independent leader in promoting healthcare quality leadership, accreditation, measurement and innovation. By achieving this status, Outpatient Pharmacy Services at Yale New Haven Health has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.
"Yale New Haven Health is proud to have earned full URAC 4.0 accreditation for Specialty Pharmacy for the second time after a rigorous preparation process," said LeeAnn Miller, VP/ Chief Pharmacy Officer, YNHHS. "This designation demonstrates that Outpatient Pharmacy Services at Yale New Haven Health is dedicated to quality and safety, and that we strive for continual improvement of the services we offer to our patients"
Outpatient Pharmacy Services at Yale New Haven Health provides a comprehensive case-managed program customized for complex diseases such as Cancer, Cystic Fibrosis, Hepatitis C, HIV, Multiple Sclerosis, Pulmonary disorders, Rheumatoid Arthritis, Growth hormone deficiency, Transplant and other specialty conditions. The specialty pharmacy team works closely with care providers to create the safest, most effective treatment program for patients; ensures timely delivery of monthly refills of specialty medications; and offers education and support from specialty pharmacists with years of experience.
"It's necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved. Outpatient Pharmacy Services at Yale New Haven Health shows a dedication to patient education and safety through the recognition of quality it received with URAC's independent accreditation," said URAC President and CEO Shawn Griffin, M.D. "With URAC accreditation, people know that Yale New Haven Health strives to adhere to industry best practices."
